M. Turner

发表

The application of a new quantitative assay for the monitoring of integrin‐associated protein CD47 on red blood cells during storage and comparison with the expression of CD47 and phosphatidylserine with flow cytometry

S. Urbaniak, A. Stewart, M. Turner, 2005, Transfusion.

Subclinical infection occurs frequently following low dose exposure to prions by blood transfusion

J. Manson, H. Brown, M. Salamat, 2022, Scientific Reports.

The release of prion protein from platelets during storage of apheresis platelets

C. Prowse, I. Macgregor, O. Drummond, 2001, Transfusion.

Is there a relationship between anti-HPA-1a concentration and severity of neonatal alloimmune thrombocytopenia?

S. Urbaniak, M. Turner, H. Bessos, 2005, Immunohematology.

The development of a quantitative ELISA for antibodies against human platelet antigen type 1a

S. Urbaniak, M. Turner, H. Bessos, 2003, Transfusion.

Neonatal alloimmune thrombocytopenia in Scotland: a national HPA-1 epidemiological study involving 26,506 pregnant women.

J. Cairns, S. Urbaniak, M. Harkness, 2002 .

Fatal COVID-19 outcomes are associated with an antibody response targeting epitopes shared with endemic coronaviruses

P. Klenerman, P. Phalora, G. Screaton, 2021, medRxiv.

THE IMPACT OF NEW‐VARIANT CREUTZFELDT‐JAKOB DISEASE ON BLOOD TRANSFUSION PRACTICE

M. Turner, 1999, British journal of haematology.

Combination therapy of infliximab and thiopurines, but not monotherapy with infliximab or vedolizumab, is associated with attenuated IgA and neutralisation responses to SARS-CoV-2 in inflammatory bowel disease

J. Satsangi, P. Klenerman, P. Simmonds, 2021, Gut.

Application of a Time‐Resolved Fluoroimmunoassay for the Analysis of Normal Prion Protein in Human Blood and Its Components

C. Prowse, M. Turner, J. Hope, 1999, Vox sanguinis.

The above letter was sent to Bessos et al.: Dr Bessos and colleagues offered the following reply

S. Urbaniak, A. Stewart, M. Turner, 2006 .

The United Kingdom Primary Immune Deficiency (UKPID) Registry: report of the first 4 years' activity 2008–2012

Smita Y. Patel, A. Gennery, S. Marshall, 2014, Clinical and experimental immunology.

In vitro amplification and detection of variant Creutzfeldt–Jakob disease PrPSc

C. Prowse, J. Ironside, J. Manson, 2007, The Journal of pathology.

New-variant Creutzfeldt-Jakob disease: the risk of transmission by blood transfusion.

M. Turner, J. Ironside, M. Turner, 1998, Blood reviews.

Variant Creutzfeldt-Jakob disease.

C. Ludlam, M. Turner, 2000, Transfusion medicine reviews.